Acknowledgements

Return to TOC | 2025 Guidelines for Stem Cell Research and Clinical Translation

Recommendations for the 2025 targeted revision of the ISSCR Guidelines were provided by the Embryo Models Working Group. The working group, its co-chairs, and the ISSCR are grateful to the many individuals and organizations who reviewed the white paper and draft guidelines and provided comments or otherwise contributed to our deliberations.

Embryo Models Working Group (2025)

Amander Clark, Co-Chair, UCLA, USA

Janet Rossant, Co-Chair, Gairdner Foundation and Hospital for Sick Children, Canada

Heidi Cook-Andersen, UCSD, USA

Sarah Franklin, University of Cambridge, UK

Rosario Isasi, University of Miami, USA

Debra Mathews, Johns Hopkins University, USA

Vincent Pasque, University of Leuven, Belgium

Peter Rugg-Gunn, Babraham Institute, UK

Patrick Tam, Children’s Medical Research Institute, Australia

Hongmei Wang, Chinese Academy of Sciences, China

Xiaomei Zhai, Chinese Academy of Medical Sciences

Jan Żylicz, Novo Nordisk Foundation for Stem Cell Medicine, Denmark

Supported by ISSCR Staff

Tyler Lamb, Director of Policy

—

The 2021 Guidelines Task Force thanks the many individuals and organizations who reviewed the draft guidelines and provided comments or otherwise contributed to our deliberations.

Task Force to Update the ISSCR Guidelines (2021)

Steering Committee

Robin Lovell-Badge, Chair, Francis Crick Institute, UK

Melissa Carpenter, ElevateBio/Carpenter GroupConsulting, USA

R. Alta Charo, University of Wisconsin, USA

Amander Clark, University of California, Los Angeles, USA

George Q. Daley, Harvard Medical School, USA

Insoo Hyun, Case Western Reserve University School of Medicine/Harvard Medical School, USA

Jürgen Knoblich, IMBA-Institute of Molecular Biotechnology, Austria

Heather Rooke, Broad Institute, USA

Janet Rossant, Gairdner Foundation/SickKids, Canada

Douglas Sipp, RIKEN Center for Developmental Biology, Japan and Keio University School of Medicine, Japan

Working Group Members

Roger Barker, Cambridge Center for Brain Repair, UK

Tania Bubela, Simon Fraser University, Canada

Ali H. Brivanlou, The Rockefeller University, USA

Ellen Clayton, Vanderbilt University, USA

Yali Cong, Peking University, China

Jianping Fu, University of Michigan, USA

Misao Fujita, Kyoto University, Japan

Andy Greenfield, MRC Harwell Institute, UK

Steve Goldman, University of Rochester Medical Center, USA

Lori Hill, MD Anderson, USA

Rosario Isasi, University of Miami, USA

Jeffrey Kahn, Johns Hopkins University, USA

Kazuto Kato, Osaka University, Japan

Jin-Soo Kim, Seoul National University, Korea

Jonathan Kimmelman, McGill University, Canada

Debra Mathews, Johns Hopkins University, USA

Nuria Montserrat, Institute for Bioengineering of Catalonia (IBEC), Spain

Megan Munsie, University of Melbourne, Australia

Hiromitsu Nakauchi, Stanford University, USA/University of Tokyo, Japan

Luigi Naldini, Università Vita-Salute San Raffaele, Italy

Gail Naughton, Histogen, USA

Kathy Niakan, Francis Crick Institute, UK

Ubaka Ogbogu, University of Alberta, Canada

Roger Pedersen, Stanford University, USA

Nicolas Rivron, IMBA-Institute of Molecular Biotechnology, Austria

Jeff Round, Institute of Health Economics, Canada

Mitinori Saitou, Kyoto University, Japan

Julie Steffann, Université Paris Descartes, France

Jeremy Sugarman, Johns Hopkins University, USA

Azim Surani, University of Cambridge, UK

Jun Takahashi, Kyoto University, Japan

Fuchou Tang, Peking University, China

Leigh Turner, University of Minnesota, USA

Patti Zettler, Ohio State University, USA

Xiaomei Zhai, Peking Union Medical College, China

Supported by ISSCR Staff

Eric Anthony, Director of Policy

Jack Mosher, Scientific Affairs, Senior Manager

Glori Rosenson, Director of Outreach